Characterization of Lysophospholipase D Activity in Mammalian Cell Membranes
Cells · 16.03.2024 · 13 (6) · 520
DOI: 10.3390/cells13060520 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 16.03.2024. Verfasst von Yuhuan Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425, USA. Hauptthemen laut MEDLINE: Apoptosis, Ovarian Neoplasms, Phosphoric Diester Hydrolases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Lysophosphatidic acid (LPA) is a lipid mediator that binds to G-protein-coupled receptors, eliciting a wide variety of responses in mammalian cells. Lyso-phospholipids generated via phospholipase A2 (PLA2) can be converted to LPA by a lysophospholipase D (lyso-PLD). Secreted lyso-PLDs have been studied in more detail than membrane-localized lyso-PLDs. This study utilized in vitro enzyme assays with fluorescent substrates to examine LPA generation in membranes from multiple mammalian cell lines (PC12, rat pheochromocytoma; A7r5, rat vascular smooth muscle; Rat-1, rat fibroblast; PC-3, human prostate carcinoma; and SKOV-3 and OVCAR-3, human ovarian carcinoma). The results show that membranes contain a lyso-PLD activity that generates LPA from a fluorescent alkyl-lyso-phosphatidylcholine, as well as from naturally occurring acyl-linked lysophospholipids. Membrane lyso-PLD and PLD activities were distinguished by multiple criteria, including lack of effect of PLD2 over-expression on lyso-PLD activity and differential sensitivities to vanadate (PLD inhibitor) and iodate (lyso-PLD inhibitor). Based on several lines of evidence, including siRNA knockdown, membrane lyso-PLD is distinct from autotaxin, a secreted lyso-PLD. PC-3 cells express GDE4 and GDE7, recently described lyso-PLDs that localize to membranes. These findings demonstrate that membrane-associated lyso-D activity, expressed by multiple mammalian cell lines, can contribute to LPA production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425, USA.
- Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA 99202, USA.
ORCID-Profile: Pravita Balijepalli
Förderung
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
- U.S. Department of Defense
- UNCF/Merck Science Research Dissertation Fellowship
- the University Research Committee of the Medical University of South Carolina
- the College of Pharmacy and Pharmaceutical Sciences at Washington State University
Zitieren
APA
Xie, Y., Ella, K. M., Gibbs, T. C., Yohannan, M. E., Knoepp, S. M., Balijepalli, P., Meier, G. P., & Meier, K. E. (2024). Characterization of Lysophospholipase D Activity in Mammalian Cell Membranes. Cells, 13(6), 520. https://doi.org/10.3390/cells13060520
Vancouver
Xie Y, Ella KM, Gibbs TC, Yohannan ME, Knoepp SM, Balijepalli P, et al. Characterization of Lysophospholipase D Activity in Mammalian Cell Membranes. Cells. 2024;13(6):520. doi:10.3390/cells13060520
BibTeX
@article{Xie2024,
author = {Xie, Yuhuan and Ella, Krishna M and Gibbs, Terra C and Yohannan, Marianne E and Knoepp, Stewart M and Balijepalli, Pravita and Meier, G Patrick and Meier, Kathryn E},
title = {Characterization of Lysophospholipase D Activity in Mammalian Cell Membranes},
journal = {Cells},
year = {2024},
volume = {13},
number = {6},
pages = {520},
doi = {10.3390/cells13060520}
}
EUVIMED